Fundraising Fox
/People
Sign in

David Donabedian

Investor

Partner, NewCo Formation at Longwood Fund · Board director at Neela Therapeutics · Executive at Newleos Therapeutics · Board director at Anuncia Medical

Find your path to David

51 people in our graph can introduce you to David.

Each arrow is one introduction. Sign up to fill in the first one.

Ask Christoph Westphal to introduce you to David

You →Christoph · together at Newleos Therapeutics →David

Ask Jamie Chen to introduce you to David

You →Jamie · 4 people · together at Newleos Therapeutics →David

Ask Sam Okafor to introduce you to David

You →Sam · together at Anuncia Medical →David

Sign up to find every way you can get introduced to David

  • Your email: the people you already email who know David
  • 2nd- and 3rd-degree connections: people you know who worked, studied or invested with David
  • Your LinkedIn: the connections who can make the intro for you

We rank every route by how warm it is, so you raise on warm intros instead of cold emails.

Sign up with GoogleAlready have an account? Log in

About

David Donabedian is a partner who specializes in NewCo formation—conceiving, creating, and staffing new biotech companies and often serving as founding or interim CEO, exemplified by Newleos Therapeutics.

Invests in

AI & Machine LearningBiotechHealthtechMedical Devices

Board director at Neela Therapeutics

Intro paths

→

In turn, David can intro founders to Neela Therapeutics's investors below.

Neela Therapeutics's investors · 1

Longwood FundBoston · since 2025

Executive at Newleos Therapeutics

Intro paths

→

In turn, David can intro founders to Newleos Therapeutics's investors below.

Newleos Therapeutics's investors · 4

DCVC (Data Collective)Palo Alto · $5M – $25M checks · since 2025DCVC BioPalo Alto · since 2025Longwood FundBoston · since 2025Novo HoldingsCopenhagen · $1.1M – $54M checks · since 2025

Board director at Anuncia Medical

Intro paths

→

In turn, David can intro founders to Anuncia Medical's investors below.

Anuncia Medical's investors · 3

Arieal Southeast Angel PartnersSavannah · $100K – $2M checksLongwood FundBoston · since 2024Xcellerant VenturesScottsdale

Deals · 4

Neela TherapeuticsBoard seat

via Longwood Fund · filed May 2026 · $21.5M raise

Anuncia MedicalBoard seat

via Longwood Fund · filed Nov 2025 · $16.4M raise

Alcyone TherapeuticsBoard seat

via Longwood Fund · filed Jan 2025 · $31.6M raise

Avaxia BiologicsBoard seat

via Longwood Fund · filed Jul 2015 · $5M raise

Attribution from SEC filings, press coverage, and firm rosters.

Colleagues at Longwood Fund

Al Sandrock
Strategic Advisory Board at Longwood Fund
Aleks Radovic-Moreno
Partner at Longwood Fund
Alex Margolin
Venture Partner at Longwood Fund
Annalisa D’Andrea
Venture Partner at Longwood Fund
Anne Klibanski
Strategic Advisory Board at Longwood Fund
Aparaajita Balaji
Associate at Longwood Fund
Arielle Jackson
Head, Corporate Communications & Industry Engagement at Longwood Fund
Barry Greene
Strategic Advisory Board at Longwood Fund

Frequently asked questions

Who is David Donabedian?
David Donabedian is a partner who specializes in NewCo formation—conceiving, creating, and staffing new biotech companies and often serving as founding or interim CEO, exemplified by Newleos Therapeutics.
Where does David Donabedian work?
David Donabedian is Partner, NewCo Formation at Longwood Fund and Board director at Neela Therapeutics and Executive at Newleos Therapeutics and Board director at Anuncia Medical.
What does David Donabedian invest in?
David Donabedian invests in AI & Machine Learning, Biotech, Healthtech, Medical Devices.
What boards does David Donabedian sit on?
David Donabedian holds tracked board seats at Alcyone Therapeutics, Anuncia Medical, Avaxia Biologics, Neela Therapeutics.

Founder mafias